Clinical Trial Update: M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating M7824 in combination with chemotherapy for stage IV non-small cell lung cancer has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• M7824 (bintrafusp alfa)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-08-21